GB Magazine July 2022 | Page 66

Research

Curebound ACCELERATING CANCER RESEARCH INTO CURES

Curebound

Launched in 2021 , Curebound is an evolution and expansion of two highly respected local cancer organizations , Padres Pedal the Cause and the Immunotherapy Foundation , which have come together to help create a robust , sustainable source of funding for cancer research in San Diego . To date , Curebound has raised over $ 23 million to fund 80 + innovative research projects , including six clinical trials , between San Diego ’ s exceptional research institutions : UC San Diego Health , Salk Institute , Rady Children ’ s Hospital , Sanford Burnham Prebys , La Jolla Institute for Immunology and Scripps Research .

With 1 in 2 men and 1 in 3 women expected to be diagnosed with cancer , Curebound ’ s mission is to mobilize San Diego to accelerate cures for cancer in our lifetime . Curebound is committed to investing $ 100 million into collaborative cancer research over the next decade and making San Diego a global center of research and the city where cures begin .
Curebound is headquartered in San Diego amidst a unique combination of three National Cancer Institute cancer centers , clinical care hospitals , biotech companies , venture capital investors , philanthropic networks and , most importantly , a regional culture that embraces the spirit of collaboration .
66 GBSAN . COM | JULY 2022